Clinical Evaluation of HHLA2 in Hormone Receptor-Positive Breast Cancer: Expression Patterns and Prognostic Implications.

Kwon MJ, Yi JM, Kim TH, Park HY

Open source

DOI
10.3390/biomedicines14092066
Published
2026 Sep 15
Container
Biomedicines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14092066,
  title = {Clinical Evaluation of HHLA2 in Hormone Receptor-Positive Breast Cancer: Expression Patterns and Prognostic Implications.},
  author = {Kwon MJ and Yi JM and Kim TH and Park HY},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14092066},
  url = {https://doi.org/10.3390/biomedicines14092066}
}

RIS

TY  - JOUR
TI  - Clinical Evaluation of HHLA2 in Hormone Receptor-Positive Breast Cancer: Expression Patterns and Prognostic Implications.
AU  - Kwon MJ
AU  - Yi JM
AU  - Kim TH
AU  - Park HY
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14092066
UR  - https://doi.org/10.3390/biomedicines14092066
ER  - 

APA

MJ, K., JM, Y., TH, K., & HY, P. (2026). Clinical Evaluation of HHLA2 in Hormone Receptor-Positive Breast Cancer: Expression Patterns and Prognostic Implications.. Biomedicines. https://doi.org/10.3390/biomedicines14092066

Source records